1. Antiemetic regimen with aprepitant in the prevention of chemotherapy-induced nausea and vomiting
    Tingting Qiu et al, 2020, Medicine CrossRef
  2. Liquid Chromatography-Mass Spectrometry-Based Plasma Metabolomics Study of the Effects of Moxibustion with Seed-Sized Moxa Cone on Hyperlipidemia
    Qinghua Shao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  3. Effect of nerve electrical stimulation for treating chemotherapy-induced nausea and vomiting in patients with advanced gastric cancer
    Wen-cheng Guo et al, 2018, Medicine CrossRef
  4. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis
    null null et al, 2021, Cochrane Database of Systematic Reviews CrossRef
  5. One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis
    Daichi Watanabe et al, 2022, The Oncologist CrossRef
  6. Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy
    Naoki Inui, 2017, Medical Oncology CrossRef
  7. Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin
    Yang Zhao et al, 2021, Therapeutics and Clinical Risk Management CrossRef
  8. Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?—a systematic review and meta-analysis
    Karin Jordan et al, 2018, Supportive Care in Cancer CrossRef
  9. Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy
    Hitoshi Kusaba et al, 2016, Medicine CrossRef
  10. Chemotherapy-Induced Nausea and Vomiting: Incidence and Management in Jordan
    Mohammad Al Qadire, 2018, Clinical Nursing Research CrossRef

  11. Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study


    Xuan Wu et al, 2020, Cancer Management and Research CrossRef
  12. Optimal prophylaxis of chemotherapy-induced nausea and vomiting for moderately emetogenic chemotherapy: a meta-analysis
    Yaxiong Zhang et al, 2018, Future Oncology CrossRef
  13. Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis
    Zhonghan Zhang et al, 2018, The Oncologist CrossRef